HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population.

Abstract
Cardiovascular diseases, including myocardial infarction (MI) and stroke, most often occur on the background of atherosclerosis, a condition attributed to the interactions between multiple genetic and environmental risk factors. We recently reported a linkage and association study of MI and stroke that yielded a genetic variant, HapA, in the gene encoding 5-lipoxygenase-activating protein (ALOX5AP), that associates with both diseases in Iceland. We also described another ALOX5AP variant, HapB, that associates with MI in England. To further assess the contribution of the ALOX5AP variants to cardiovascular diseases in a population outside Iceland, we genotyped seven single-nucleotide polymorphisms that define both HapA and HapB from 450 patients with ischemic stroke and 710 controls from Aberdeenshire, Scotland. The Icelandic at-risk haplotype, HapA, had significantly greater frequency in Scottish patients than in controls. The carrier frequency in patients and controls was 33.4% and 26.4%, respectively, which resulted in a relative risk of 1.36, under the assumption of a multiplicative model (P=.007). We did not detect association between HapB and ischemic stroke in the Scottish cohort. However, we observed that HapB was overrepresented in male patients. This replication of haplotype association with stroke in a population outside Iceland further supports a role for ALOX5AP in cardiovascular diseases.
AuthorsA Helgadottir, S Gretarsdottir, D St Clair, A Manolescu, J Cheung, G Thorleifsson, A Pasdar, S F A Grant, L J Whalley, H Hakonarson, U Thorsteinsdottir, A Kong, J Gulcher, K Stefansson, M J MacLeod
JournalAmerican journal of human genetics (Am J Hum Genet) Vol. 76 Issue 3 Pg. 505-9 (Mar 2005) ISSN: 0002-9297 [Print] United States
PMID15640973 (Publication Type: Journal Article)
Chemical References
  • 5-Lipoxygenase-Activating Proteins
  • ALOX5AP protein, human
  • Carrier Proteins
  • Membrane Proteins
Topics
  • 5-Lipoxygenase-Activating Proteins
  • Aged
  • Carrier Proteins (genetics)
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genetic Variation
  • Genotype
  • Haplotypes
  • Humans
  • Iceland
  • Male
  • Membrane Proteins (genetics)
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Scotland
  • Stroke (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: